Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Sell
9
MOH Quote, Financials, Valuation and Earnings
Last price:
$182.99
Seasonality move
:
-2.35%
Day range:
$182.09 - $204.39
52-week range:
$182.09 - $365.23
Dividend yield:
0%
P/E ratio:
8.84x
P/S ratio:
0.25x
P/B ratio:
2.30x
Volume:
3.6M
Avg. volume:
977.2K
1-year change:
-36.41%
Market cap:
$9.9B
Revenue:
$40.7B
EPS (TTM):
$20.71
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MOH
Molina Healthcare
|
$11B | $5.57 | 10.82% | 19.82% | $310.22 |
|
CI
The Cigna Group
|
$62.6B | $7.15 | 3.55% | 30.86% | $374.26 |
|
CNC
Centene
|
$44.3B | $0.30 | 12.25% | -5.01% | $54.74 |
|
ELV
Elevance Health
|
$48.2B | $8.92 | 8.51% | 71.54% | $423.49 |
|
OSCR
Oscar Health
|
$2.9B | $0.36 | 27.98% | 138.85% | $14.99 |
|
UNH
UnitedHealth Group
|
$111.6B | $4.57 | 13.15% | 11% | $380.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MOH
Molina Healthcare
|
$182.98 | $310.22 | $9.9B | 8.84x | $0.00 | 0% | 0.25x |
|
CI
The Cigna Group
|
$295.71 | $374.26 | $79B | 16.37x | $1.51 | 1.97% | 0.32x |
|
CNC
Centene
|
$27.95 | $54.74 | $13.9B | 4.17x | $0.00 | 0% | 0.08x |
|
ELV
Elevance Health
|
$277.09 | $423.49 | $62.4B | 11.79x | $1.71 | 2.41% | 0.34x |
|
OSCR
Oscar Health
|
$13.42 | $14.99 | $3.4B | 47.93x | $0.00 | 0% | 0.37x |
|
UNH
UnitedHealth Group
|
$282.65 | $380.75 | $256.4B | 11.84x | $2.21 | 3.01% | 0.64x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MOH
Molina Healthcare
|
45.33% | -0.690 | 20.09% | 1.57x |
|
CI
The Cigna Group
|
43.08% | 0.324 | 34.23% | 0.81x |
|
CNC
Centene
|
39.62% | -0.165 | 60.45% | 1.07x |
|
ELV
Elevance Health
|
40.84% | -0.061 | 34.47% | 2.04x |
|
OSCR
Oscar Health
|
18.36% | 3.823 | 9.01% | 1.09x |
|
UNH
UnitedHealth Group
|
46.1% | -0.007 | 16.7% | 0.77x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MOH
Molina Healthcare
|
$1.3B | $433M | 16.29% | 25.66% | 3.89% | $168M |
|
CI
The Cigna Group
|
-- | -- | 6.86% | 12.17% | 3.07% | $1.6B |
|
CNC
Centene
|
$5.2B | $1.5B | 7.62% | 12.65% | 4.11% | $1.4B |
|
ELV
Elevance Health
|
-- | -- | 7.44% | 12.52% | 5.29% | $1.8B |
|
OSCR
Oscar Health
|
-- | -- | 8.58% | 10.83% | 9.66% | $869.5M |
|
UNH
UnitedHealth Group
|
$23.8B | $9.1B | 12.37% | 21.74% | 8.31% | $4.6B |
Molina Healthcare vs. Competitors
-
Which has Higher Returns MOH or CI?
The Cigna Group has a net margin of 2.67% compared to Molina Healthcare's net margin of 2.02%. Molina Healthcare's return on equity of 25.66% beat The Cigna Group's return on equity of 12.17%.
Company Gross Margin Earnings Per Share Invested Capital MOHMolina Healthcare11.48% $5.45 $7.9B CIThe Cigna Group-- $4.85 $70.9B -
What do Analysts Say About MOH or CI?
Molina Healthcare has a consensus price target of $310.22, signalling upside risk potential of 69.54%. On the other hand The Cigna Group has an analysts' consensus of $374.26 which suggests that it could grow by 26.56%. Given that Molina Healthcare has higher upside potential than The Cigna Group, analysts believe Molina Healthcare is more attractive than The Cigna Group.
Company Buy Ratings Hold Ratings Sell Ratings MOHMolina Healthcare6 9 0 CIThe Cigna Group13 6 0 -
Is MOH or CI More Risky?
Molina Healthcare has a beta of 0.551, which suggesting that the stock is 44.891% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.446, suggesting its less volatile than the S&P 500 by 55.43%.
-
Which is a Better Dividend Stock MOH or CI?
Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 1.97% to investors and pays a quarterly dividend of $1.51 per share. Molina Healthcare pays -- of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MOH or CI?
Molina Healthcare quarterly revenues are $11.1B, which are smaller than The Cigna Group quarterly revenues of $65.5B. Molina Healthcare's net income of $298M is lower than The Cigna Group's net income of $1.3B. Notably, Molina Healthcare's price-to-earnings ratio is 8.84x while The Cigna Group's PE ratio is 16.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.25x versus 0.32x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MOHMolina Healthcare0.25x 8.84x $11.1B $298M CIThe Cigna Group0.32x 16.37x $65.5B $1.3B
-
Which has Higher Returns MOH or CNC?
Centene has a net margin of 2.67% compared to Molina Healthcare's net margin of 2.81%. Molina Healthcare's return on equity of 25.66% beat Centene's return on equity of 12.65%.
Company Gross Margin Earnings Per Share Invested Capital MOHMolina Healthcare11.48% $5.45 $7.9B CNCCentene11.16% $2.63 $46.3B -
What do Analysts Say About MOH or CNC?
Molina Healthcare has a consensus price target of $310.22, signalling upside risk potential of 69.54%. On the other hand Centene has an analysts' consensus of $54.74 which suggests that it could grow by 95.83%. Given that Centene has higher upside potential than Molina Healthcare, analysts believe Centene is more attractive than Molina Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings MOHMolina Healthcare6 9 0 CNCCentene7 12 0 -
Is MOH or CNC More Risky?
Molina Healthcare has a beta of 0.551, which suggesting that the stock is 44.891% less volatile than S&P 500. In comparison Centene has a beta of 0.439, suggesting its less volatile than the S&P 500 by 56.078%.
-
Which is a Better Dividend Stock MOH or CNC?
Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MOH or CNC?
Molina Healthcare quarterly revenues are $11.1B, which are smaller than Centene quarterly revenues of $46.6B. Molina Healthcare's net income of $298M is lower than Centene's net income of $1.3B. Notably, Molina Healthcare's price-to-earnings ratio is 8.84x while Centene's PE ratio is 4.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.25x versus 0.08x for Centene. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MOHMolina Healthcare0.25x 8.84x $11.1B $298M CNCCentene0.08x 4.17x $46.6B $1.3B
-
Which has Higher Returns MOH or ELV?
Elevance Health has a net margin of 2.67% compared to Molina Healthcare's net margin of 3.5%. Molina Healthcare's return on equity of 25.66% beat Elevance Health's return on equity of 12.52%.
Company Gross Margin Earnings Per Share Invested Capital MOHMolina Healthcare11.48% $5.45 $7.9B ELVElevance Health-- $7.72 $74B -
What do Analysts Say About MOH or ELV?
Molina Healthcare has a consensus price target of $310.22, signalling upside risk potential of 69.54%. On the other hand Elevance Health has an analysts' consensus of $423.49 which suggests that it could grow by 52.84%. Given that Molina Healthcare has higher upside potential than Elevance Health, analysts believe Molina Healthcare is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings MOHMolina Healthcare6 9 0 ELVElevance Health13 5 0 -
Is MOH or ELV More Risky?
Molina Healthcare has a beta of 0.551, which suggesting that the stock is 44.891% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.605, suggesting its less volatile than the S&P 500 by 39.515%.
-
Which is a Better Dividend Stock MOH or ELV?
Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 2.41% to investors and pays a quarterly dividend of $1.71 per share. Molina Healthcare pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MOH or ELV?
Molina Healthcare quarterly revenues are $11.1B, which are smaller than Elevance Health quarterly revenues of $49.8B. Molina Healthcare's net income of $298M is lower than Elevance Health's net income of $1.7B. Notably, Molina Healthcare's price-to-earnings ratio is 8.84x while Elevance Health's PE ratio is 11.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.25x versus 0.34x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MOHMolina Healthcare0.25x 8.84x $11.1B $298M ELVElevance Health0.34x 11.79x $49.8B $1.7B
-
Which has Higher Returns MOH or OSCR?
Oscar Health has a net margin of 2.67% compared to Molina Healthcare's net margin of 9.04%. Molina Healthcare's return on equity of 25.66% beat Oscar Health's return on equity of 10.83%.
Company Gross Margin Earnings Per Share Invested Capital MOHMolina Healthcare11.48% $5.45 $7.9B OSCROscar Health-- $0.92 $1.6B -
What do Analysts Say About MOH or OSCR?
Molina Healthcare has a consensus price target of $310.22, signalling upside risk potential of 69.54%. On the other hand Oscar Health has an analysts' consensus of $14.99 which suggests that it could grow by 11.73%. Given that Molina Healthcare has higher upside potential than Oscar Health, analysts believe Molina Healthcare is more attractive than Oscar Health.
Company Buy Ratings Hold Ratings Sell Ratings MOHMolina Healthcare6 9 0 OSCROscar Health2 2 3 -
Is MOH or OSCR More Risky?
Molina Healthcare has a beta of 0.551, which suggesting that the stock is 44.891% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MOH or OSCR?
Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare pays -- of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MOH or OSCR?
Molina Healthcare quarterly revenues are $11.1B, which are larger than Oscar Health quarterly revenues of $3B. Molina Healthcare's net income of $298M is higher than Oscar Health's net income of $275.3M. Notably, Molina Healthcare's price-to-earnings ratio is 8.84x while Oscar Health's PE ratio is 47.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.25x versus 0.37x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MOHMolina Healthcare0.25x 8.84x $11.1B $298M OSCROscar Health0.37x 47.93x $3B $275.3M
-
Which has Higher Returns MOH or UNH?
UnitedHealth Group has a net margin of 2.67% compared to Molina Healthcare's net margin of 5.74%. Molina Healthcare's return on equity of 25.66% beat UnitedHealth Group's return on equity of 21.74%.
Company Gross Margin Earnings Per Share Invested Capital MOHMolina Healthcare11.48% $5.45 $7.9B UNHUnitedHealth Group21.7% $6.85 $186.4B -
What do Analysts Say About MOH or UNH?
Molina Healthcare has a consensus price target of $310.22, signalling upside risk potential of 69.54%. On the other hand UnitedHealth Group has an analysts' consensus of $380.75 which suggests that it could grow by 34.71%. Given that Molina Healthcare has higher upside potential than UnitedHealth Group, analysts believe Molina Healthcare is more attractive than UnitedHealth Group.
Company Buy Ratings Hold Ratings Sell Ratings MOHMolina Healthcare6 9 0 UNHUnitedHealth Group13 6 1 -
Is MOH or UNH More Risky?
Molina Healthcare has a beta of 0.551, which suggesting that the stock is 44.891% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.449, suggesting its less volatile than the S&P 500 by 55.115%.
-
Which is a Better Dividend Stock MOH or UNH?
Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 3.01% to investors and pays a quarterly dividend of $2.21 per share. Molina Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MOH or UNH?
Molina Healthcare quarterly revenues are $11.1B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Molina Healthcare's net income of $298M is lower than UnitedHealth Group's net income of $6.3B. Notably, Molina Healthcare's price-to-earnings ratio is 8.84x while UnitedHealth Group's PE ratio is 11.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.25x versus 0.64x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MOHMolina Healthcare0.25x 8.84x $11.1B $298M UNHUnitedHealth Group0.64x 11.84x $109.6B $6.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
